The WORLD LEADER in Immune Complex and VECTOR vaccine technology
TRANSMUNE® IBD: Immune complex technology against IBD
Infectious Bursal Disease (IBD) has been a long standing challenge in the field. Producers needed a vaccine that worked in the presence of a relatively high level of maternal antibodies. In response, Ceva developed Transmune® IBD, a unique vaccine utilizing upgraded immune complex technology that eliminated the difficulties of vaccinating for IBD by overcoming the challenge of when to vaccinate and the problem of non-uniform administration in the chicken house. It also made it possible to provide lifetime protection against all forms of IBD with a single dose administered via in ovo (in the egg) or subcutaneous injection.
VECTORMUNE®: The broadest range of disease protection in a vector vaccine line
VECTORMUNE® vaccines are the next generation of poultry vaccines. These vector vaccines express the major immunogenic proteins to block any viruses. Thereby, level of protection is much higher and lasts for the life of the bird regardless of the level of maternal immunity. VECTORMUNE® vaccines are genetically engineered using Marek’s Disease virus or Fowl Pox viruses to express key protective antigens against Newcastle Disease(VECTORMUNE® ND), Avian Influenza(VECTORMUNE® AI), Laryngothacheitis (VECTORMUNE® FP LT and VECTORMUNE® LT) and Mycoplasma (VECTORMUNE® FP MG)
CEVAC® VITABRON L®: Provides a unique solution for day-old vaccination
The day-old vaccination of chicks is critical to achieve good priming and build a strong basis for the field life and possible revaccination against Newcastle Disease and Infectious Bronchitis. However, it can induce detrimental post vaccination reaction in the young bird. To overcome this problem, Ceva developed a unique vaccine combination of PHY.LMV.42 apathogenic enterotropic strain of Newcastle Disease virus and the Massachusetts H120 strain of Infectious Bronchitis virus that allows a safe and efficacious spray application at day-old in the hatchery.
LAYERMUNE® SE: Still setting the standard in salmonella protection
Ceva received the first USDA license for a poultry vaccine against S. enteritidis. Introduced in 1992, LAYERMUNE® SE has been instrumental in earning Ceva the #1 ranking in salmonella vaccines in the U.S. With the concern of S. enteritidis to human health, the proven efficacy of LAYERMUNE® SE quickly expanded Ceva’s worldwide reach.
CEVAC CORYMUNE® RANGE: Broad spectrum Infectious Coryza and Salmonella Enteritidis (SE) vaccine
Reducing the number of vaccinations by combining the protection of Infectious Coryza, main viral diseases and SE in one vaccine:
CEVAC® Corymune 4K is the first inactivated vaccine combining broad Infectious Coryza protection (serotype A, B, C) and SE in one vaccine. The vaccine is with an Aluminium Hydroxide adjuvant for undisrupted growth in pullets. CEVAC® Corymune 7K long lasting immunity during the egg production period by combining protection against Infectious Coryza (serotypes A, B, C), SE, Infectious Bronchits, Egg Drop Syndrome and Newcastle disease.
CEVAC IBIRD®: INFECTIOUS BRONCHITIS UNDER CONTROL FROM THE HATCHERY
Infectious bronchitis causes severe economic losses in both broilers and laying hens. It is highly contagious and is present all over the world. Infectious bronchitis is characterized by its capacity to mutate and new variants appear in the field frequently. Cevac IBird® is a live attenuated vaccine (strain 1/96) belonging to 793 B group and able to induce strong protection against 793 B virus strain. Cevac IBird® in combination with a Massachusetts vaccine strain administered at day of age is able to offer a wider protection for QX, Q1 or J2 infectious bronchitis virus strains isolated from different parts of the world.
CEVAC MAREK'S RANGE: IMMUNO-POTENT MAREK'S VACCINE
Marek's disease is prevalent worldwide caused by Herpes virus and all flocks are exposed to the virus. Marek's disease not only cause tumour lesion but also immunosuppressive especially very virulent plus (vv+) Marek's. One-day-old chicks are most at risk if not properly immunized with protective vaccines. Ceva’s Marek’s vaccines has been proven to give protection against all Marek’s field virusesincluding the very virulent + Marek’s disease virus. Ceva Rispens strain is a immune potent strain derived from original European Rispens strain, CVI 988 strain isolated in chickens in 1972 in the Netherlands, with a low passage level to provide strong Marek’s disease protection.
All the detailed information about the Ceva Poultry Vaccines range is also available on "The Poultry Site" by clicking here.
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the Ceva Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.